Cleared Traditional

K232172 - BTL-785BNF Handpiece

K232172 is the FDA 510(k) clearance for BTL-785BNF Handpiece by BTL Industries, Inc.. It is a Class 2 Neurology device (product code NFO) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K232172 · BTL Industries, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
59d
Days
Class 2
Risk

K232172 is an FDA 510(k) clearance for the BTL-785BNF Handpiece. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by BTL Industries, Inc. (Marlborough, US). The FDA issued a Cleared decision on September 18, 2023 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all BTL Industries, Inc. devices

Submission Details

510(k) Number K232172 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2023
Decision Date September 18, 2023
Days to Decision 59 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 148d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K232172.
Nu Skin RenuSpa iO
K232001 · Nse Products, Inc. · Nov 2023
Beagank 4T Plus
K233010 · Belega, Inc. · Nov 2023
C.C. Life 21
K230459 · 21 Equipment S.R.L. · Oct 2023
Medi Lift PLUS
K220198 · Ya-Man, Ltd. · Jun 2023
PureLift Pro Edition
K230506 · Xtreem Pulse · Jun 2023
Myolift QT
K213078 · Johari Digital Healthcare Limited · Apr 2023